Posaconazole Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-12-02 · last update 2025-12-02
Manufacturers: Merck Sharp & Dohme Corp.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01) | Merck Sharp & Dohme Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/02/2025 Updated 12/02/2025 Discontinued 12/02/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)